‹ Knowledge base
Browse the corpus
Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.
- Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data1 passage
- Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials1 passage
- Evidence-based guidelines for the pharmacological treatment of migraine1 passage
- Evidence-based guidelines for the pharmacological treatment of migraine, summary version1 passage
- International Headache Society global practice recommendations for the acute pharmacological treatment of migraine1 passage
- Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis1 passage
- Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis1 passage
- The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis1 passage